Anti‐vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Anti‐vascular Endothelial Growth Factor for Macular Oedema Secondary to Branch Retinal Vein Occlusion." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433643/0/Lithium_for_schizophrenia:_Cochrane_systematic_review. Accessed 20 April 2024.
Anti‐vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433643/0/Lithium_for_schizophrenia:_Cochrane_systematic_review. Accessed April 20, 2024.
Anti‐vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/433643/0/Lithium_for_schizophrenia:_Cochrane_systematic_review
Anti‐vascular Endothelial Growth Factor for Macular Oedema Secondary to Branch Retinal Vein Occlusion [Internet]. In: Cochrane Abstracts. [cited 2024 April 20]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433643/0/Lithium_for_schizophrenia:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Anti‐vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion
ID - 433643
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433643/0/Lithium_for_schizophrenia:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -